000 01027 a2200289 4500
005 20250514170819.0
264 0 _c20040220
008 200402s 0 0 eng d
022 _a1533-4406
040 _aNLM
_beng
_cNLM
100 1 _aSchillaci, Giuseppe
245 0 0 _aXimelagatran versus warfarin after total knee replacement.
_h[electronic resource]
260 _bThe New England journal of medicine
_cFeb 2004
300 _a616-7; author reply 616-7 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aArthroplasty, Replacement, Knee
650 0 4 _aAzetidines
_xtherapeutic use
650 0 4 _aBenzylamines
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aThromboembolism
_xprevention & control
650 0 4 _aWarfarin
_xtherapeutic use
700 1 _aPasqualini, Leonella
700 1 _aMannarino, Elmo
773 0 _tThe New England journal of medicine
_gvol. 350
_gno. 6
_gp. 616-7; author reply 616-7
999 _c14491499
_d14491499